Literature DB >> 11529745

Structure-activity studies of antitumor agent irofulven (hydroxymethylacylfulvene) and analogues.

T C McMorris1, J Yu, R Lira, R Dawe, J R MacDonald, S J Waters, L A Estes, M J Kelner.   

Abstract

Many analogues of the antitumor agent irofulven have been readily prepared by replacing the allylic hydroxyl with a variety of nucleophiles. Analogues of acylfulvene (the precursor to irofulven) were also prepared by Michael reaction with acrolein. The toxicity of the analogues was determined, as well as preclinical antitumor activity. Several analogues exhibited good activity in mouse xenografts. Structural requirements for activity are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11529745     DOI: 10.1021/jo010458z

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  3 in total

1.  Enantioselective total synthesis of (-)-acylfulvene and (-)-irofulven.

Authors:  Dustin S Siegel; Grazia Piizzi; Giovanni Piersanti; Mohammad Movassaghi
Journal:  J Org Chem       Date:  2009-12-18       Impact factor: 4.354

2.  Antitumor Effects of a New Retinoate of the Fungal Cytotoxin Illudin M in Brain Tumor Models.

Authors:  Benedikt Linder; Miroslava Zoldakova; Zsuzsanna Kornyei; Leonhard H F Köhler; Sebastian Seibt; Dominic Menger; André Wetzel; Emília Madarász; Rainer Schobert; Donat Kögel; Bernhard Biersack
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

Review 3.  Nature curing cancer - review on structural modification studies with natural active compounds having anti-tumor efficiency.

Authors:  Gurpreet Kaur; Neelam Verma
Journal:  Biotechnol Rep (Amst)       Date:  2015-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.